Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
34
-
Total shares
-
7.49M
-
Shares change
-
+2M
-
Total reported value, excl. options
-
$50.6M
-
Value change
-
+$12.3M
-
Number of buys
-
27
-
Number of sells
-
-14
-
Price
-
$6.75
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q2 2014
34 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q2 2014.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.49M shares
.
Largest 10 shareholders include Aisling Capital LLC (1.76M shares), JPMORGAN CHASE & CO (1.3M shares), Cormorant Asset Management, LLC (1M shares), Talkot Capital, LLC (696K shares), FMR LLC (641K shares), VANGUARD GROUP INC (374K shares), BlackRock Institutional Trust Company, N.A. (247K shares), BAIRD ROBERT W & CO INC /WI/ (211K shares), Healthcare Value Capital, LLC (205K shares), and NOMURA HOLDINGS INC (198K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.